TY  - GEN
AU  - Karanikas,V
AU  - Thynne,G
AU  - Mitchell,P
AU  - Ong,C S
AU  - Gunawardana,D
AU  - Blum,R
AU  - Pearson,J
AU  - Lodding,J
AU  - Pietersz,G
AU  - Broadbent,R
AU  - Tait,B
AU  - McKenzie,I F
TI  - Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection
SN  - 1524-9557
PY  - 2001///0531
KW  - Adenocarcinoma
KW  - immunology
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies
KW  - blood
KW  - Breast Neoplasms
KW  - Colonic Neoplasms
KW  - Cyclophosphamide
KW  - administration & dosage
KW  - Cytotoxicity, Immunologic
KW  - Humans
KW  - Hypersensitivity, Delayed
KW  - Immunity, Cellular
KW  - Immunotherapy, Active
KW  - Injections, Intramuscular
KW  - Injections, Intraperitoneal
KW  - Lymphocyte Activation
KW  - Mannans
KW  - Middle Aged
KW  - Mucin-1
KW  - Neoplasms
KW  - Recombinant Fusion Proteins
KW  - T-Lymphocytes
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
ER  -